Cosmetic OEM / ODM product platform
Soothing Repair Peptide Microneedle Patch
Cosmetic soothing and barrier-care concepts for blemish-prone skin positioning.






AI-generated product & process concepts. Final specifications are project-dependent.
HYTANBIO · Changzhou base
110-needle blemish microdart platform
The blemish platform uses HA arrays with 110 needles per patch and a nominal height range of 300–1,000 µm. Six packaging counts are listed: one, two, three, six, eight or nine patches. The geometry-led formulation reference contains salicylic acid, asiaticoside and PDRN; a separate botanical profile uses plant-derived salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate, with six-, eight- or nine-patch stock-pack references. Ingredient names matter: salicin is not salicylic acid, and madecassoside is not asiaticoside. Select a single approved formulation profile before sampling. PDRN identity, source, intended route and classification need specific review. The portfolio’s acne-care positioning must be checked for the launch market; product naming alone does not substantiate acne treatment. Backing, tray, size and color complete the product brief.

OEM / ODM configuration
Blemish / acne microdart patch
- Array material: Hyaluronic acid (HA)
- Nominal needle height: 300–1,000 µm
- Needles per patch: 110
- Patches per pack: 1 / 2 / 3 / 6 / 8 / 9
- Backing options: PE / PU / TPU / hydrocolloid
- Other options: Tray, size and color
Geometry-led blemish profile
Ingredient reference: Salicylic acid, asiaticoside and PDRN
Targeted blemish-patch research configuration
Botanical blemish-care profile
Ingredient reference: Plant-derived salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate
Blemish-prone skin and the appearance of post-blemish marks; catalogue acne-care positioning requires market review
Pack: 6 / 8 / 9 patches
Salicin and salicylic acid are different ingredients; asiaticoside and madecassoside are different ingredients. PDRN identity, source, quality and intended delivery route require a separate safety and classification assessment. No acne-treatment result is established.








Buyer questions
Which blemish pack sizes are listed?
The geometry-led format lists 1, 2, 3, 6, 8 or 9 patches per pack, with 110 needles per patch.
Are the two blemish formulations identical?
No. One lists salicylic acid, asiaticoside and PDRN; the other lists salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate. These are separate configurations.
Portfolio specifications updated October 15, 2026 · HYTANBIO product portfolio, pages 14, 16. Final configuration and evidence requirements are agreed per project.
Platform overview
Designed as a customizable commercial starting point
Core peptide direction
Candidate peptides are screened against intended positioning, compatibility, processing conditions and the final test plan. Final INCI and concentration are project-specific.
Microneedle specification
Needle height, array density, patch size and dissolution profile are selected for the cosmetic application area and manufacturing feasibility.
Private-label options
Custom logo, high-barrier pouch, retail carton, instructions and multipack configuration can be coordinated under one project.
What can be customized
Formula & performance brief
- Single or multi-peptide blend direction
- Supporting cosmetic ingredients
- Concentration and compatibility targets
- Stability and packaging test plan
Physical & brand specification
- Patch shape and dimensions
- Needle height and array pattern
- Pouch, carton and logo artwork
- Sample, pilot and mass-production route
